Nonalcoholic Steatohepatitis (NASH) Report

By www.reportprimer.com

Report Details

Report Name

Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2023 Story

Pages

86

Price

$ 2900

Features

Nonalcoholic Steatohepatitis (NASH) Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead